---
$id: https://graph.org.ai/products/commodity/51142547
$type: Product
source: UNSPSC
code: "51142547"
title: "Bromocriptine methanesulfonate"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Bromocriptine methanesulfonate

**UNSPSC Code**: 51142547
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a neuroprotective agent with the molecular formula C32H40BrN5O5.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FFP983J3OD, chemically known as ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, monomethanesulfonate (salt), (5'.alpha.)-, but more generally known as bromocriptine methanesulfonate, which bears US NIH Compound Identifier 31100. European Medicines Agency schedules bromocriptine methanesulfonate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05918MIG. Most nations, for tariff purposes, schedule bromocriptine methanesulfonate under HS 29396900. SMILES: CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6C7C(CCCC7[NH]C6BR)C5=C4)C)O.CS(=O)(=O)O.

